Bactiguard strengthens licensing with Anders Göransson entering new role as Global Head of Licensing. Thomas von Koch appointed interim CEO RegulatoryMay 21, 2023 22:45 CEST
Invitation to presentation of Bactiguard’s report for the first quarter 2023 April 21, 2023 10:30 CEST
Clinical study launched to compare efficacy of Bactiguard coated central venous catheters with non-coated April 12, 2023 09:00 CEST
Notice to attend the Annual General Meeting of Bactiguard Holding AB RegulatoryApril 3, 2023 09:05 CEST
Invitation to presentation of Bactiguard’s year-end report for 2022 on February 9, 2023 February 6, 2023 11:32 CET
Nomination Committee appointed for the Annual General Meeting 2023 RegulatoryNovember 1, 2022 16:15 CET
Invitation to presentation of Bactiguard’s interim report on October 27, 2022 October 24, 2022 14:45 CEST
Senior management and key employees in Bactiguard have acquired call options in Bactiguard issued by the main owners, comprising shares corresponding to 4 percent of all shares in Bactiguard May 13, 2022 08:00 CEST
Bulletin from Bactiguard Holding AB’s (publ) Annual General Meeting RegulatoryApril 29, 2022 11:45 CEST
Invitation to the presentation of Bactiguard’s interim report for the first quarter and ahead of the AGM 2022 April 22, 2022 08:30 CEST
Notice to attend the Annual General Meeting of Bactiguard Holding AB RegulatoryMarch 29, 2022 11:30 CEST
Bactiguard presents focused growth strategy and sets new long-term financial targets RegulatoryFebruary 8, 2022 22:55 CET
Bactiguard will publish its year-end report for 2021 tonight at 23.00 RegulatoryFebruary 8, 2022 20:35 CET
Clinical study on Bactiguard’s endotracheal tube now published – shows significant reduction of ventilator-associated pneumonia January 10, 2022 13:30 CET
Gabriella Björknert Caracciolo has today announced that she will leave the role as CFO and deputy CEO for Bactiguard Holding AB (publ) RegulatoryDecember 13, 2021 08:00 CET
Nomination Committee appointed for the Annual General Meeting 2022 RegulatoryOctober 29, 2021 08:00 CEST
Invitation to presentation of Bactiguard’s interim report on October 28, 2021 October 25, 2021 08:00 CEST
New clinical trial shows 53% reduction of ventilator-associated pneumonia with Bactiguard’s endotracheal tube October 5, 2021 08:00 CEST
Bactiguard completes a directed new share issue to AMF, raising approximately SEK 228 million RegulatorySeptember 22, 2021 00:07 CEST
Bactiguard-coated Zimmer Biomet trauma implants for infection prevention launched in select EMEA markets June 15, 2021 08:30 CEST
Bulletin from Bactiguard Holding AB’s (publ) Annual General Meeting RegulatoryApril 28, 2021 12:00 CEST
Invitation to the presentation of Bactiguard’s interim report for the first quarter and ahead of the AGM 2021 April 19, 2021 08:00 CEST
Notice to attend the Annual General Meeting of Bactiguard Holding AB RegulatoryMarch 26, 2021 11:00 CET
A large randomized clinical trial shows significant reduction in urinary tract infections March 11, 2021 18:00 CET
Health Canada provides COVID-19 Interim Order approval for Bactiguard’s TempSensor catheter February 9, 2021 09:00 CET
Invitation to presentation of Bactiguard’s year-end report for 2020 on February 4, 2021 February 1, 2021 08:30 CET
Bactiguard-coated Zimmer Biomet trauma implants receive European regulatory clearance RegulatoryJanuary 21, 2021 18:30 CET
Bactiguard maintains clear growth strategy and updates financial targets RegulatoryNovember 5, 2020 07:55 CET
Invitation to presentation of Bactiguard’s interim report on November 5, 2020 November 2, 2020 08:00 CET
Nomination Committee appointed for the Annual General Meeting 2021 RegulatoryOctober 29, 2020 16:32 CET
Bactiguard recruits experienced Chief Marketing and Communications Officer October 13, 2020 13:05 CEST
Health Canada provides COVID-19 Interim Order approval for Bactiguard’s endotracheal tubes August 12, 2020 17:00 CEST
Invitation to the presentation of Bactiguard’s interim report on August 13, 2020 August 10, 2020 08:30 CEST
Bactiguard initiates collaboration with online pharmacy Apotea on sales of Hydrocyn® aqua RegulatoryJune 3, 2020 11:05 CEST
Bulletin from Bactiguard Holding AB’s (publ) Annual General Meeting 2020 RegulatoryApril 28, 2020 15:15 CEST
Information about the Annual General Meeting 2020 and invitation to CEO presentation RegulatoryApril 20, 2020 08:00 CEST
Bactiguard launches catheter for patients in need of continuous temperature monitoring April 1, 2020 08:30 CEST
Notice to attend the Annual General Meeting of Bactiguard Holding AB 2020 RegulatoryMarch 27, 2020 14:00 CET
Bactiguard and Svenskt Industriflyg establish air bridge for protective medical equipment March 18, 2020 13:30 CET
Bactiguard has received orders of over SEK 20 million for product that protects against Coronavirus RegulatoryMarch 17, 2020 13:45 CET
Christian Kinch resigns as CEO of Bactiguard and is proposed as new Chairman of the Board. Cecilia Edström appointed new CEO. RegulatoryFebruary 4, 2020 22:15 CET
Invitation to presentation of Bactiguard’s year end report for 2019 on February 5, 2020 January 28, 2020 15:45 CET
Invitation to presentation of Bactiguard’s interim report on November 7, 2019 November 4, 2019 08:00 CET
Nomination Committee appointed for the Annual General Meeting 2020 RegulatoryOctober 23, 2019 08:00 CEST
Bactiguard’s urinary catheters approved for reimbursement in the Dutch market September 10, 2019 08:00 CEST
Invitation to the presentation of Bactiguard’s interim report on August 8, 2019 August 5, 2019 15:00 CEST
New Swedish study shows that long-term use of Bactiguard coated Foley catheters reduce infections June 27, 2019 08:00 CEST
Bactiguard receives research grant from Vinnova for developing vascular stents May 23, 2019 08:00 CEST
Bulletin from Bactiguard Holding AB’s (publ) Annual General Meeting 2019 RegulatoryMay 15, 2019 16:50 CEST
Notice to attend the Annual General Meeting of Bactiguard Holding AB 2019 RegulatoryApril 15, 2019 08:00 CEST
The Nomination Committee proposes Professor Anna Martling and Thomas von Koch as new Board members RegulatoryApril 12, 2019 14:00 CEST
Invitation to presentation of Bactiguard’s year end report for 2018 on February 7, 2019 February 4, 2019 13:00 CET
CE-mark opens the door to billion-dollar market for orthopaedic trauma implants RegulatoryDecember 5, 2018 08:00 CET
Invitation to presentation of Bactiguard’s interim report on November 6, 2018 October 31, 2018 08:00 CET
Nomination Committee appointed for the Annual General Meeting 2019 RegulatoryOctober 12, 2018 08:00 CEST
The shareholder base in Bactiguard is broadened through a transaction comprising 6.6 million shares RegulatorySeptember 10, 2018 08:30 CEST
Invitation to presentation of Bactiguard’s interim report on August 8, 2018 August 1, 2018 08:00 CEST
Bactiguard takes the next step in China and signs agreement worth more than SEK 30 million RegulatoryJuly 2, 2018 08:00 CEST
Bulletin from Bactiguard Holding AB’s (publ) Annual General Meeting 2018 RegulatoryMay 16, 2018 18:00 CEST
Bactiguard’s licensing partner Smartwise enters collaboration with AstraZeneca May 7, 2018 08:00 CEST
Invitation to presentation of Bactiguard’s year end report for 2017 on February 6, 2018 January 31, 2018 08:00 CET
The Nomination Committee proposes that Jan Ståhlberg is elected new member of the Board and Chairman of Bactiguard Holding AB (publ) RegulatoryJanuary 22, 2018 08:00 CET
New clinical study shows fewer adverse events with Bactiguard’s central venous catheter compared to a standard central venous catheter November 10, 2017 08:00 CET
Invitation to presentation of Bactiguard’s interim report on November 9, 2017 November 6, 2017 08:05 CET
Invitation to presentation of Bactiguard’s interim report on August 10, 2017 August 7, 2017 08:00 CEST
New clinical study from Hong Kong confirms that Bactiguard coated Foley catheters reduce infections for long-term users February 21, 2017 08:00 CET
Bactiguard enters new therapeutic area through license agreement with Smartwise AB RegulatoryFebruary 7, 2017 08:00 CET
Invitation to presentation of Bactiguard’s year end report for 2016 on February 9, 2017 February 6, 2017 08:00 CET
Invitation to presentation of Bactiguard’s interim report on November 10, 2016 November 7, 2016 08:15 CET
New clinical study confirms that Bactiguard coated Foley catheters reduce infections in ICU October 26, 2016 08:00 CEST
Bactiguard continues cooperation with the Swedish counties Kronoberg and Blekinge October 17, 2016 08:00 CEST
New clinical study at the Martini-Klinik to improve care for prostate cancer patients September 13, 2016 09:05 CEST
Invitation to presentation of Bactiguard’s interim report on August 11, 2016 August 8, 2016 08:00 CEST
Notice to attend the Annual General Meeting of Bactiguard Holding AB 2016 RegulatoryApril 19, 2016 08:00 CEST
A year of positive volume and earnings growth, ending with the product approval in China RegulatoryFebruary 18, 2016 08:00 CET
Invitation to presentation of Bactiguard’s year end report for 2015 on February 18 RegulatoryFebruary 15, 2016 08:00 CET
Changes to the Nomination Committee appointed for the Annual General Meeting 2016 RegulatoryDecember 10, 2015 08:00 CET
Nomination Committee appointed for the Annual General Meeting 2016 RegulatoryNovember 18, 2015 08:00 CET
Bactiguard enters new therapeutic area through license agreement RegulatoryNovember 11, 2015 08:20 CET
New clinical studies show that Bactiguard-coated catheters reduce hospital acquired infections September 14, 2015 08:00 CEST
Bactiguard expands in Europe – new distribution agreement for Switzerland RegulatoryMarch 12, 2015 12:55 CET
An eventful year, focused on building a platform for future growth RegulatoryFebruary 19, 2015 08:00 CET
Invitation to presentation of Bactiguard’s year end report for 2014 on February 19 RegulatoryFebruary 16, 2015 08:00 CET
Nomination Committee appointed for the Annual General Meeting 2015 RegulatoryNovember 24, 2014 08:30 CET
Bactiguard strengthens the organization for the next development phase RegulatoryNovember 14, 2014 08:00 CET
Invitation to presentation of Bactiguard’s interim report on November 14 RegulatoryNovember 11, 2014 08:30 CET
Bactiguard reports increased revenues and improved EBITDA for the second quarter 2014 RegulatoryAugust 15, 2014 08:00 CEST
Invitation to presentation of Bactiguard’s interim report for the second quarter on August 15 RegulatoryAugust 12, 2014 15:15 CEST
Bactiguard strengthens its sales organization by appointing Erik Düring head of European sales RegulatoryJuly 9, 2014 08:00 CEST
Increased number of shares and votes in Bactiguard Holding AB (publ) RegulatoryJune 30, 2014 07:00 CEST
Bactiguard coated Foleys show significant reduction in symptomatic urinary tract infections June 27, 2014 09:30 CEST
Bactiguard prices its initial public offering at SEK 38 per B share – trading commences on NASDAQ OMX Stockholm today RegulatoryJune 19, 2014 07:00 CEST
Bactiguard launches offer, publishes prospectus and sets price range for listing on NASDAQ OMX Stockholm June 9, 2014 19:59 CEST
Poland last week and now Romania – Bactiguard signs new contracts in Europe November 14, 2013 10:42 CET
Azerbaijan, Kazakhstan and Uzbekistan – three new countries for Bactiguard November 6, 2013 10:24 CET
Oman and Pakistan – two new countries for Bactiguard’s infection protection control May 24, 2013 09:09 CEST
Ecuador – the first South American country to receive Bactiguard’s portfolio for Infection Control May 15, 2013 08:59 CEST
Swedish medtech company Bactiguard’s Infection Control portfolio now in Bosnia May 6, 2013 08:42 CEST
Bactiguard’s Endotracheal Tube and Central Venous Catheter available in the Middle East markets January 28, 2013 15:15 CET
Swedish medtech company Bactiguard receives market authorization in Mexico January 25, 2013 16:46 CET
Bactiguard® is entering the Russian Market together with its new partner Intermedservice January 23, 2013 14:41 CET
Swedish Bactiguard to enter into an exclusive distribution agreement with Cadila Pharmaceuticals February 21, 2012 10:02 CET
Bactiguard collaborates with The Innovation Center at Karolinska University Hospital for the future of healthcare October 18, 2011 09:23 CEST
Minister for Health and Social Affairs, Göran Hägglund, visits Bactiguard to study solutions for hospital acquired infections September 30, 2008 10:39 CEST
